IT

Iterumtx

1 known investors

iterumtx.com ↗

Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens. The company's lead product, sulopenem (ORLYNVAH), has been approved by the FDA for treating uncomplicated urinary tract infections in adult women.

Investors · 1

SO

Sofinnova VenturesMenlo Park